chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on both arms, wrists and hands.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0172) via an unspecified route of administration in the left arm on 30Apr2021 at 14:15 as a single dose for COVID-19 immunisation. Medical history included unspecified allergies. Concomitant medications included loratadine (CLARITIN) and vitamin D (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 14:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 14:30, the patient experienced rash on both arms, wrists and hands. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rash on both arms, wrists and hands was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
On 8/23 I started to have mild symptoms and on 8/24 I tested positive for COVID-19. So far my symptoms have not been severe or required hospitalization but I was and am symptomatic.
patient said he felt hot after receiving vaccine, pharmacist immediately took emergency cart out to the patient and assessed him- he looked a little sweaty- took patients BP it was 84/60- pharmacist stayed with patient and asked about any other symptoms- he stated he had none- retook BP in 10 mins it was 123/74- pharmacist continued to stay with the patient for an additional 30 minutes - he was reassessed after and had no signs of any issues so he went home- pharmacist called him later and checked on him- he stated no more issues
Patient came in 2 days later with parent, mom states patient had inflammation around injection site. No pain or itchiness, patient's mom stated it kept getting larger in the last 24 hours. Provider diagnosed it as Cellulitis on left thigh, patient was prescribed mupirocin 2% topical ointment and cephalexin 125mg/5ml oral suspension. Patient's mom was advised by the provider if the injection site gets worse and the medications aren't helping to go to the Emergency Room.
pt recv vax 6OCT95 & 7MAR97 pt exp a mild case of chickenpox;
Patient developed full body , red scaly, itch rash. Also muscle tightness that developed in the patients back specifically that caused her "back to go out".
16 year old patient was given second dose of MENQUADFI. The first dose was one month ago with no adverse event; Initial information received on 21-Mar-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 16 years old female patient who was given second dose of  MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI]. however, the first dose was one month ago with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO) for Prophylactic vaccination; and INFLUENZA VACCINE (FLUZONE [INFLUENZA VACCINE]) for Prophylactic vaccination.  On 21-Mar-2023, the patient received dose 2 (once) of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE, Solution for injection (lot U7447AB, expiry date: 20-Sep-2024) (unknown strength)via intramuscular route in the left deltoid for immunization.  On 21-Mar-2023 reporter reported that 16 year old patient was given second dose of menquadfi. the first dose was one month ago with no adverse event (inappropriate schedule of product administration) (latency: same day).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for an event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Little bit of liquid leaked out  while administering the vaccine; Liquid mixed with blood while administering the vaccine; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SYRINGE ISSUE (Little bit of liquid leaked out  while administering the vaccine) and UNDERDOSE (Liquid mixed with blood while administering the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced SYRINGE ISSUE (Little bit of liquid leaked out  while administering the vaccine) and UNDERDOSE (Liquid mixed with blood while administering the vaccine). On 04-Jun-2021, SYRINGE ISSUE (Little bit of liquid leaked out  while administering the vaccine) and UNDERDOSE (Liquid mixed with blood while administering the vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information was received on 13-JUL-2017 from a 63 year old female consumer regarding herself.  Medical history/concurrent conditions included osteoporosis, rheumatoid arthritis, Epstein Barr virus, allergies to Codeine, Naproxen, FELDENE, Sulfur, Tramadol and latex. Concomitant medications were reported as none. On 10-JUL-2017, the patient was vaccinated with ZOSTAVAX (dose, route, site of administration and lot number not reported) for the prevention of shingles. She reported that "since she got the ZOSTAVAX vaccine she has been experiencing hair loss and also has a red spot around the injection site 2-3 inches wide and 5 inches long." She has not sought medical attention. No additional information was provided. The relationship between the events and ZOSTAVAX was not provided. Additional information has been requested.
coughing; fever 100.0; fatigue; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COUGH (coughing), PYREXIA (fever 100.0) and FATIGUE (fatigue) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 immunisation.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced COUGH (coughing), PYREXIA (fever 100.0) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COUGH (coughing), PYREXIA (fever 100.0) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant product usage were not reported by the reporter.
Received the meningitis vaccine on Monday, June 6, 2005 at approx. 11:00 a.m. She experienced tenderness in the sight of the injection.  On Tuesday, June 7,2005 she complained of a headache and stomach-ache, she had a fever of 102.8 degrees. These symptoms lasted all day and throughout the night.  On Wednesday, June 8,2005 she awoke feeling fine, but by noon of that day she was running a fever of 102.6, had a headache,and was extremely tired. This lasted for the rest of the day and evening. Thurdsay morning, she was fine, no fever. Approx. 7:00 p.m. she complained of being very tired - again a fever or 102 degrees.  The same on Friday - she was fine during the day but about 7:00 p.m. she ran a fever of 101 degrees.  Saturday, June 11,2005 awoke feeling fine but at approx 9:30 a.m. she complained of an itching feeling on her back.  She had a terrible red, hot raised rash all over her back, chest, neck and behind her ears. Benadryl has been given - the rash seems to fade and the itching subsides only to return every 4 hours.
This spontaneous prospective pregnancy report as received from a 35 year old female consumer refers to herself. On 04-JUN-2014 the patient was vaccinated with M-M-R II (lot# H017433, exp. 20-SEP-2014) 0.5 ml, subcutaneous. The consumer reported that she became pregnant within 3 weeks of receiving M-M-R II. The patient became pregnant with date of last menstrual period (LMP) of 09-MAY-2014 based on by subtracting the gestational age from 27-JUN-2014 and estimated delivery date (EDD) of 13-FEB-2015. Date of conception based on first day of the last menstrual period was 23-MAY-2014. On 23-JUN-2014 pregnancy test was performed. Additional information has been requested.
Patient developed chest pain on 7/13, 2 days after 1st vaccine dose.
large Red swollen warm to touch LUArm 16cm ht by 0.5cm wide. Was provided Dexamethasone 6mg IM or wait to fill antibiotic Keflex 500mg tid.
Pfizer booster; blood clot two; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 immunisation. The following information was reported: IMMUNISATION (hospitalization, medically significant), outcome "unknown", described as "Pfizer booster"; THROMBOSIS (hospitalization, medically significant), outcome "unknown", described as "blood clot two". The reporter stated reporter's father was in the hospital with a blood clot two. The symptoms started two days after the Pfizer booster.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pain at injection site; Headache; Body ache; Painful stomach ache; Upset stomach; A spontaneous report was received from a consumer concerning a 29-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain at injection site, headache, body ache, painful stomach ache, upset stomach.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On 21 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 02020M20A) via unknown route for prophylaxis of COVID-19 infection.  On 21 Feb 2021, the patient experienced the event(s) pain at injection site, headache, body ache, painful stomach ache, upset stomach.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), pain at injection site, headache, body ache, painful stomach ache, upset stomach was unknown.
When I received my vaccine, I waited 15 minutes at pharmacy and didn't notice any adverse symptoms. But around 4:00 pm, I stood up and noticed that my knees were swollen, popping and cracking when I walked. I have never had any problems with my knees, and exercise regularly, so at first I thought is was just a weird Covid side affect...but I couldn't find that particular symptom on the list of Covid vaccine side effects.  I took 2 Alleve and applied Arnica Gel to my knees. A couple hours later, my fingers, hands and wrists felt swollen.  Then overnight, I noticed that I started to feel itchy, tingly in random spots all over my body. But I did not develop a rash.  The next morning, my face was swollen, my throat felt sore/tight, everything  felt puffy and swollen. My daughter asked me if I got Botox because "my wrinkles were gone"!! That's when I knew it was an allergic reaction. I took 2 Benedryls and just napped all day. I continued taking Benedryl for 2 days, and eventually the symptoms went away.  Other than swelling, I only had mild muscle pain at the injection site. No fever or muscle pain, just swelling and the tingly itchiness all over.  However, the joint discomfort in my knees and hands is still there.
Painful shoulder. feels inflammed, difficult mobility, feels like joint is off- hearing and feeling clicking when moving shoulder or arm, less strength in shoulder/arm,. Started  in morning 4 days ago and not better now. I did not injure my shoulder or arm- did not do anything strenous. I have not reported to doctor yet- waiting a couple more days
Phone call received at 9:30am 11/16/05 from worksite that pt c/o sore throat, swelling and was not ill. Advised office person to have pt seen by physician ASAP. Work to await next call as pt did not have a cell phone. Called at 9:50am from work site as a 3 way with pt now in out of town. Pt stated that around 11:30am on 11/13 he felt like his throat was swelling, sore and had chills. Denies any other symptoms. Advised to seek medical help ASAP. Call placed to work site 11/17, unknown if pt went to doctor but is working.
Pt experienced "heart racing" followed by "jittery/nervous felling". Pt took alprazolam, which helped calmed her  and heart. Symptoms returned next morning, called pharmacy at 1pm. Instructed to call MD, who instructed pt to take another, alprazolam; which helped to relieve symptoms. Pt reports getting several in past with no problems.
swelling of the back of her neck and spine; swelling of the back of her neck and spine/ neck was swollen; States it felt duller than normal to the touch and she felt it a little on the left side of her face; pain going from the base of her neck to the left shoulder; States it felt inflamed/ she is concerned, is wondering if its normal or just inflammation; pain on the back of her neck, that traveled down to the left side of her body during the day; pain on the back of her neck, that traveled down to the left side of her body during the day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 34-year-old female patient received BNT162b2 (BNT162B2), on 14Apr2022 as dose 3 (booster), single (Lot number: FK9894) at the age of 34 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Chronic neck and jaw pain" (unspecified if ongoing), notes: Chronic neck and jaw pain; "Chronic neck and jaw pain" (unspecified if ongoing), notes: Chronic neck and jaw pain. There were no concomitant medications. Vaccination history included: BNT162b2 (First Dose of the Pfizer Covid Vaccine:  , Lot Number: FC3182; , NDC and Expiry Date unknown; , Received in the caller's left arm.), administration date: 10Sep2021, when the patient was 34-year-old, for Covid-19 immunization; BNT162b2 (Second Dose of the Pfizer Covid Vaccine: , Lot Number: Reported as being either 3013518A or 3013519A; , NDC and Expiry Date unknown; , Received in the caller's left arm.), administration date: 01Oct2021, when the patient was 34-year-old, for Covid-19 immunization. The following information was reported: FACIAL PAIN (non-serious) with onset 14Apr2022, outcome "unknown", described as "States it felt duller than normal to the touch and she felt it a little on the left side of her face"; INFLAMMATION (non-serious) with onset 14Apr2022, outcome "unknown", described as "States it felt inflamed/ she is concerned, is wondering if its normal or just inflammation"; ARTHRALGIA (non-serious) with onset 14Apr2022, outcome "not recovered", described as "pain going from the base of her neck to the left shoulder"; NECK PAIN (non-serious) with onset 14Apr2022, outcome "unknown", PAIN (non-serious) with onset 14Apr2022, outcome "not recovered" and all described as "pain on the back of her neck, that traveled down to the left side of her body during the day"; SWELLING (non-serious) with onset 14Apr2022, outcome "unknown", described as "swelling of the back of her neck and spine/ neck was swollen"; SWELLING (non-serious), outcome "unknown", described as "swelling of the back of her neck and spine".
Redness of arm - 4PM took 2 BENADRYL 10PM took 1 BENADRYL. Awakened at 2AM on 3/29/18 and took ADVIL. 3/29/18 at 8AM saw Dr about rxn, prescribed BACTRIM DS, 20 1 BID for cellulitis.
"pt recv vax 5SEP96 & w/in 24-36 hr p/vax pt exp a fever of 101.7, regressed to point that pt stopped talking;devel erratic eye movement, shivering, hypersensitivity to sounds, began to sleep poorly;stopped walking, dec vocabulary, clinging
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 27-JUL-2017, the patient was vaccinated with ZOSTAVAX lot # M027117, expiry date 26-JUL-2017 for prophylaxis. Concomitant therapies included sterile diluent. On 27-JUL-2017, the patient experienced expired product administered. On an unknown date, the patient experienced no adverse event. The outcome of expired product administered and no adverse event is unknown. The reporter considered expired product administered and no adverse event to be not related to ZOSTAVAX. Additional information has been requested.
pain on her leg; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) Pfizer Sponsored Program COVAX Support. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Batch/Lot number: unknown) as dose  1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain on her leg". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Patient received the 1st dose on 15Apr2021 and she is scheduled to get the 2nd dose tomorrow. She was asking us to send someone to her house to administer the vaccine because of the pain on her leg. She mentioned that it is sore because she has not taken her pain medication.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Mom reports blood in stool. Began 8/17/10, noticed one episode. Restarted again 8/26/10, then 8/27/10 and also 8/28/10. Unable to test stool patient out of state.
This spontaneous report was received from a medical assistant who referred to an unspecified number of patients of unknown demographics. No information regarding the patients' pertinent medical history, concomitant therapies and drug reactions or allergies was provided. On unknown date, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 lot# N010105 with expiration date: 15-NOV-2018 (dose and route of administration were not reported) as prophylaxis. The sterile diluent (manufacturer unknown) used was stored properly (lot# and expiration date not reported). The doses of vaccine were stored between 47 degrees Fahrenheit (F) to 77F for 3 hours and 18 minutes. No previous temperature excursions were detected. Digital data logger was involved. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA006289: US-009507513-1707USA009050: US-009507513-1707USA009051: US-009507513-1707USA009052: US-009507513-1707USA009054: US-009507513-1707USA009055: US-009507513-1707USA009056: US-009507513-1707USA009057.
This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 24-DEC-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L012479, expiry date 10-APR-2017, dose and route of administration were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
It effected me primarily with system as I had some chills, a fever and it lasted about 2 weeks. I had some coughing and I was fatigued. When I caught COVID-19 it was from my wife on January 5 after I took her to the hospital on January 4th.
OBSTRUCTIVE SLEEP APNEA 1/17/2023  -  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from contactable reporter (Nurse). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 21Dec2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 60 years, in right arm for COVID-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "Erosive lichen planus" (unspecified if ongoing); "Hypothyroid" (unspecified if ongoing); "Migraines" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (20Jan2023) Negative; (unspecified date) Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid 12Jan2023 to 16Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initially after vaccine, I felt fatigued with a headache for several hours which subsided with some rest. For months following vaccination, I have had intermittent congestion, frequent headaches, excessive fatigue, sore throat with raspy voice, and feeling motion sick with difficulty focusing vision during any movement.  On June 5, 2021 I went to urgent care to be further evaluated due to acute increase in symptoms including losing voice and painful swallowing. I was negative for all tests completed. Acute exacerbation resolved after 2 weeks, but mild ongoing symptoms continue. I have always been a very healthy person until I was vaccinated. I feel my immune system is not working for me anymore.
24 hours after having the second montero vac i started with a headach the i got chilly but had a temp of 101 felt like a truck hot me but then the next moring i was fine with my first shot in the left arm i got a big red spot on my arm 5 days later whick went away in about a week
With in 5-10 mins of receiving vaccine, pt became extremely nauseated and tired. "bottomed out". He vomited in the ER, broke out in a cold sweat. ER MD said episode was not related to vaccine.